Cargando…

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome

Detalles Bibliográficos
Autores principales:	Tsareva, Natalia A., Avdeev, Sergey N., Kosanovic, Djuro, Schermuly, Ralph Theo, Trushenko, Natalia V., Nekludova, Galina V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294235/ https://www.ncbi.nlm.nih.gov/pubmed/34289888 http://dx.doi.org/10.1186/s13054-021-03690-7

Ejemplares similares

Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
por: Kosanovic, Djuro, et al.
Publicado: (2021)

Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Using TAPSE (tricuspid annular plane systolic excursion) as a predictor of poor prognosis of COVID-19: is it enough?
por: Nekludova, Galina V., et al.
Publicado: (2021)

Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Pain, Swelling and Blue Discoloration of Right Hand in a COVID-19 Patient
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Can lung ultrasound predict histologic pattern of lung injury in critically ill patients with COVID‑19?
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
por: Wang, Lan, et al.
Publicado: (2017)

Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study
por: Avdeev, Sergey N., et al.
Publicado: (2021)

Effects of inhaled iloprost on acute respiratory distress syndrome in prone and supine positions
por: Senturk, E, et al.
Publicado: (2009)

Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis
por: Trushenko, Natalia V., et al.
Publicado: (2023)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
por: Schermuly, Ralph Theo, et al.
Publicado: (2005)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
por: Neupane, Balram, et al.
Publicado: (2020)

Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties
por: Luitel, Himal, et al.
Publicado: (2020)

Large Cavitary Lung Lesions in a Patient with Severe COVID-19 Pneumonia
por: Avdeev, Sergey, et al.
Publicado: (2022)

Inhaled iloprost for the control of pulmonary hypertension
por: Krug, Sabine, et al.
Publicado: (2009)

How can we predict the failure of awake proning in acute hypoxemic respiratory failure associated with COVID-19?
por: Avdeev, Sergey N., et al.
Publicado: (2022)

Differential Alterations of the Mitochondrial Morphology and Respiratory Chain Complexes during Postnatal Development of the Mouse Lung
por: El-Merhie, Natalia, et al.
Publicado: (2017)

Natural plant products in treatment of pulmonary arterial hypertension
por: Xiang, Lili, et al.
Publicado: (2018)

Inhaled iloprost for the treatment of patient with Fontan circulation
por: Kim, Yong Hyun, et al.
Publicado: (2014)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)

Review of inhaled iloprost for the control of pulmonary artery hypertension in children
por: Tissot, Cecile, et al.
Publicado: (2009)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally
por: Gredic, Marija, et al.
Publicado: (2023)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007)

COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
por: Filippini, Alida, et al.
Publicado: (2021)

Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
por: Sydykov, Akylbek, et al.
Publicado: (2021)

Use of Inhaled Iloprost in an Infant With Bronchopulmonary Dysplasia and Pulmonary Artery Hypertension
por: Hwang, Seung-Kyung, et al.
Publicado: (2009)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
por: Yıldırım, Şükran
Publicado: (2023)

Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
por: Mamazhakypov, Argen, et al.
Publicado: (2021)

Enhanced inflammatory cell profiles in schistosomiasis-induced pulmonary vascular remodeling
por: Ali, Zahara, et al.
Publicado: (2017)

Acute hemodynamic effect of inhaled iloprost in pulmonary artery hypertension evaluated with echocardiography
por: Loureiro, Maria José, et al.
Publicado: (2007)

Inhaled Iloprost for Patients With Precapillary Pulmonary Hypertension and Right-Side Heart Failure
por: Martischnig, Amadea M., et al.
Publicado: (2011)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

Inhaled iloprost can improve oxygenation and shunt fraction in severe COVID-19
por: Serbanescu-Kele Apor de Zalán, Christiaan M.C., et al.
Publicado: (2022)

Accidental inhalation injury of phosgene gas leading to acute respiratory distress syndrome
por: Kumar, Anand, et al.
Publicado: (2012)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jedojh4gj6da85ljc6un3nsvvs